ADAPTIVE BIOTECHNOLOGIES COR's ticker is and the CUSIP is 00650F959. A total of 3 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3 | -95.8% | 600 | -94.3% | 0.00% | – |
| Q2 2023 | $71 | +73.2% | 10,600 | +125.5% | 0.00% | – |
| Q1 2023 | $41 | +310.0% | 4,700 | +235.7% | 0.00% | – |
| Q4 2022 | $10 | -99.9% | 1,400 | -33.3% | 0.00% | – |
| Q3 2022 | $14,000 | -46.2% | 2,100 | -36.4% | 0.00% | – |
| Q2 2022 | $26,000 | -91.2% | 3,300 | -84.5% | 0.00% | – |
| Q1 2022 | $295,000 | +264.2% | 21,300 | +634.5% | 0.00% | – |
| Q4 2021 | $81,000 | +88.4% | 2,900 | +163.6% | 0.00% | – |
| Q3 2021 | $43,000 | -2.3% | 1,100 | 0.0% | 0.00% | – |
| Q2 2021 | $44,000 | -95.5% | 1,100 | +349.0% | 0.00% | -100.0% |
| Q1 2021 | $986,000 | +5700.0% | 245 | +8066.7% | 0.00% | – |
| Q4 2020 | $17,000 | -94.7% | 3 | -95.5% | 0.00% | – |
| Q3 2020 | $320,000 | -63.8% | 66 | -63.9% | 0.00% | -100.0% |
| Q2 2020 | $885,000 | +3440.0% | 183 | +1933.3% | 0.00% | – |
| Q1 2020 | $25,000 | -3.8% | 9 | 0.0% | 0.00% | – |
| Q4 2019 | $26,000 | -64.9% | 9 | -62.5% | 0.00% | – |
| Q3 2019 | $74,000 | – | 24 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 700 | $34,000 | 0.00% |
| SIMPLEX TRADING, LLC | 66 | $320,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |